High-fat diet impairs satiation signaling in obese-prone

February 27, 2013
High-fat diet impairs satiation signaling in obese-prone
Feeding obese-prone rats a high-fat diet leads to impaired satiation signaling through glucagon-like peptide-1, a gastrointestinal hormone that suppresses food intake and helps regulate energy balance, according to a study published online Feb. 19 in Diabetes.

(HealthDay)—Feeding obese-prone rats a high-fat diet leads to impaired satiation signaling through glucagon-like peptide-1 (GLP-1), a gastrointestinal hormone that suppresses food intake and helps regulate energy balance, according to a study published online Feb. 19 in Diabetes.

Frank A. Duca, Ph.D., from the Institut National de la Recherche Agronomique in Jouy-en-Josas, France, and colleagues compared in obese-prone and obese-resistant rats fed either normally or a high-energy/high-fat diet, after treatment with the GLP-1 receptor (GLP-1R) agonist exendin-4 or vehicle.

The researchers found that, while exendin-4 suppressed food intake in both types of rats when fed a normal diet, exendin-4 suppressed food intake significantly less in obese-prone rats than obese-resistant rats when fed a high-energy/high-fat diet. Obese-prone rats on a high-energy/high-fat diet had lower GLP-1R expression in the vagal nodose ganglia, less GLP-1 in serum and the , and fewer L-cells in the distal ileum.

"These results demonstrate that high-energy/high-fat-feeding coupled with obese-prone phenotype results in reduced endogenous GLP-1 and GLP-1R activation, indicating that impaired GLP-1 signaling during obesity may exacerbate hyperphagia and weight gain," Duca and colleagues conclude.

Explore further: Gut hormone leads to weight loss in overweight or obese patients

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Importance of diabetes genetic variants unclear

April 4, 2012

(HealthDay) -- Genetic variants associated with type 2 diabetes that affect glucagon-like peptide 1 (GLP-1) are not associated with GLP-1 levels or GLP-1-induced insulin secretion in healthy individuals, according to a study ...

Recommended for you

Gut bacteria imbalance increases diabetes risk

July 13, 2016

Currently, scientists think the major contributors to insulin resistance are excess weight and physical inactivity, yet ground-breaking new research by an EU funded European-Chinese team of investigators called MetaHit have ...

Which diabetes drug is best?

July 19, 2016

(HealthDay)—No single drug to treat type 2 diabetes stands out from the pack when it comes to reducing the risks of heart disease, stroke or premature death, a new research review finds.

Team explores genetic architecture of type 2 diabetes

July 11, 2016

New research from a large international team of scientists offers a more complete picture of the genes responsible for type 2 diabetes, demonstrating that previously identified common alleles shared by many in the world are ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.